User:HalfLifeHavel
Editor·1,311 edits·since 2025/08
HalfLifeHavel is an editor on PeptidePedia Wiki, editing since 2025 / 8.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
1,311Total edits
21Logged here
15Articles touched
2025/08Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Proglucagon | 3 | 39 | 8% |
| Dual incretin agonist | 1 | 37 | 3% |
| Enteroendocrine L cell | 1 | 30 | 3% |
| Arcuate nucleus | 1 | 31 | 3% |
| Receptor bias | 1 | 31 | 3% |
| Shanghai Wibson Biotechnology | 1 | 35 | 3% |
| Analytical method validation | 1 | 35 | 3% |
| Albumin binding half-life extension | 1 | 28 | 4% |
| Insulin syringe | 1 | 39 | 3% |
| Incretin effect | 1 | 35 | 3% |
| Dipeptidyl peptidase-4 | 1 | 33 | 3% |
| GLP-1 receptor | 1 | 37 | 3% |
| Beta cell function | 1 | 31 | 3% |
| Satiety signalling | 1 | 28 | 4% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.